What is Replimune Group's D&A?

Replimune Group (REPL) reported D&A of $800K in Q4 2025.

How has Replimune Group's D&A changed year-over-year?

Replimune Group's D&A decreased by 20.0% year-over-year, from $1M to $800K.

What is the long-term trend for Replimune Group's D&A?

Over 3 years (2022 to 2025), Replimune Group's D&A has grown at a 17.5% compound annual growth rate (CAGR), from $2.15M to $3.48M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Replimune Group REPL D&A

D&A at other companies

AmgenAMGN

$1.12B-19.5%

Regeneron PharmaceuticalsREGN

$123.2M-2.9%

Inhibrx Biosciences, Inc.INBX

$537K-20.4%

ImmunomeIMNM

$603K-1.3%

CG OncologyCGON

$841K+3,404%

Erasca, Inc.ERAS

$723K-12.0%

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$919.03M+28.6%

Enterprise value$873.59M+28.3%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's D&A?: Replimune Group (REPL) reported D&A of $800K in Q4 2025.
How has Replimune Group's D&A changed year-over-year?: Replimune Group's D&A decreased by 20.0% year-over-year, from $1M to $800K.
What is the long-term trend for Replimune Group's D&A?: Over 3 years (2022 to 2025), Replimune Group's D&A has grown at a 17.5% compound annual growth rate (CAGR), from $2.15M to $3.48M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.